• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,847.57 -702.68
( -0.91%)
Global Indices
Nasdaq
48,242.37 304.80
(0.64%)
Dow Jones
6,907.55 69.66
(1.02%)
Hang Seng
57,815.15 1,312.38
(2.32%)
Nikkei 225
10,580.14 -20.39
(-0.19%)
Forex
USD-INR
93.15 0.65
(0.70%)
EUR-INR
109.13 1.08
(1.00%)
GBP-INR
125.28 1.20
(0.96%)
JPY-INR
0.58 0.00
(0.42%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
Feb 13,2026
Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.